ARCH Venture Partners VIII, LLC's Net Worth

$720 Million

Estimate Recalculated Feb 20, 2024 05:40PM EST

Who is ARCH Venture Partners VIII, LLC?

ARCH Venture Partners VIII, LLC has an estimated net worth of $720 Million. This is based on reported shares across multiple companies, which include Neumora Therapeutics, Inc., Scholar Rock Holding Corp, Quanterix Corp, Denali Therapeutics Inc., Twist Bioscience Corp, Metacrine, Inc., Unity Biotechnology, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., and Homology Medicines, Inc..

SEC CIK

ARCH Venture Partners VIII, LLC's CIK is 0001616165

Past Insider Trading and Trends

2018 was ARCH Venture Partners VIII, LLC's most active year for acquiring shares with 18 total transactions. ARCH Venture Partners VIII, LLC's most active month to acquire stocks was the month of August. 2018 was ARCH Venture Partners VIII, LLC's most active year for disposing of shares, totalling 17 transactions. ARCH Venture Partners VIII, LLC's most active month to dispose stocks was the month of April. 2023 saw ARCH Venture Partners VIII, LLC paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2020 ARCH Venture Partners VIII, LLC cashed out on 30,643,367 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Scholar Rock Holding Corp (SRRK) Snapshot price: $16.06

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.64M
2.64M
May 29
Form 3
0
0
No matching records found

Denali Therapeutics Inc. (DNLI) Snapshot price: $16.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.61%
-400.00K
10.67M
Aug 8
Form 4
+3,442.00%
10.76M
11.07M
Dec 12
Form 3
0
0
No matching records found

Metacrine, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.94M
$13.00
2.94M
Sep 18
Form 3
0
0
No matching records found

Unity Biotechnology, Inc. (UBX) Snapshot price: $1.7389

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25,308.20%
10.01M
10.05M
May 7
Form 3
0
0
No matching records found

Codiak BioSciences, Inc. (CDAKQ) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+129.73%
5M
$1.50
$7,500,000.00
8.85M
Sep 13
Form 4
+75.61%
3.79M
$15.00
$3,525,000.00
8.8M
Oct 16
Form 3
0
0
No matching records found